# CION Investment Corp: financial statements, quarterly

CION · NYSE · CIK 1534254 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cion.md) · [Financials](/companies/cion/financials.md) · [Filings](/companies/cion/filings.md) · [Insiders](/companies/cion/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cion/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [21.8](/filings/0001534254-23-000018.md) | [24.0 d](/filings/0001534254-24-000017.md) | [24.3](/filings/0001534254-24-000012.md) | [23.8](/filings/0001534254-24-000017.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [47.5](/filings/0001534254-25-000004.md) | [51.0](/filings/0001534254-25-000004.md) | [6.4](/filings/0001534254-26-000003.md) | [22.4](/filings/0001534254-26-000003.md) | [(0.4)](/filings/0001534254-26-000003.md) | [5.5](/filings/0001534254-26-000003.md) | [(42.7)](/filings/0001534254-26-000006.md) | [27.3](/filings/0001534254-26-000010.md) | [35.9](/filings/0001534254-26-000003.md) | [(41.1)](/filings/0001534254-26-000003.md) | [(23.0)](/filings/0001534254-26-000006.md) | [31.0](/filings/0001534254-26-000010.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.8](/filings/0001534254-23-000018.md) | [8.4](/filings/0001534254-25-000004.md) | [48.5](/filings/0001534254-24-000012.md) | [9.8](/filings/0001534254-24-000017.md) | [29.8](/filings/0001534254-24-000020.md) | [7.7](/filings/0001534254-26-000003.md) | [7.7](/filings/0001534254-25-000009.md) | [6.5](/filings/0001534254-25-000012.md) | [3.9](/filings/0001534254-25-000015.md) | [8.2](/filings/0001534254-26-000010.md) | [9.2](/filings/0001534254-26-000006.md) | [7.7](/filings/0001534254-26-000010.md) |
| Total assets | $m | [1,896](/filings/0001534254-23-000018.md) | [2,002](/filings/0001534254-25-000004.md) | [1,968](/filings/0001534254-24-000012.md) | [1,960](/filings/0001534254-24-000017.md) | [1,916](/filings/0001534254-24-000020.md) | [1,946](/filings/0001534254-26-000003.md) | [1,896](/filings/0001534254-25-000009.md) | [1,881](/filings/0001534254-25-000012.md) | [1,884](/filings/0001534254-25-000015.md) | [1,855](/filings/0001534254-26-000010.md) | [1,844](/filings/0001534254-26-000006.md) | [1,847](/filings/0001534254-26-000010.md) |
| Total liabilities | $m | [1,036](/filings/0001534254-23-000018.md) | [1,122](/filings/0001534254-25-000004.md) | [1,105](/filings/0001534254-24-000012.md) | [1,100](/filings/0001534254-24-000017.md) | [1,076](/filings/0001534254-24-000020.md) | [1,125](/filings/0001534254-26-000003.md) | [1,140](/filings/0001534254-25-000009.md) | [1,122](/filings/0001534254-25-000012.md) | [1,111](/filings/0001534254-25-000015.md) | [1,147](/filings/0001534254-26-000010.md) | [1,184](/filings/0001534254-26-000006.md) | [1,179](/filings/0001534254-26-000010.md) |
| Long-term debt | $m | [1,000](/filings/0001534254-23-000018.md) | [1,082](/filings/0001534254-25-000004.md) | [1,060](/filings/0001534254-24-000012.md) | [1,062](/filings/0001534254-24-000017.md) | [1,055](/filings/0001534254-24-000020.md) | [1,099](/filings/0001534254-26-000003.md) | [1,100](/filings/0001534254-25-000009.md) | [1,102](/filings/0001534254-25-000012.md) | [1,079](/filings/0001534254-25-000015.md) | [1,126](/filings/0001534254-26-000010.md) | [1,158](/filings/0001534254-26-000006.md) | [1,160](/filings/0001534254-26-000010.md) |
| Shareholders' equity | $m | [861](/filings/0001534254-24-000020.md) | [880](/filings/0001534254-26-000003.md) | [863](/filings/0001534254-25-000015.md) | [861](/filings/0001534254-25-000015.md) | [839](/filings/0001534254-25-000015.md) | [821](/filings/0001534254-26-000010.md) | [757](/filings/0001534254-26-000010.md) | [759](/filings/0001534254-26-000010.md) | [773](/filings/0001534254-26-000010.md) | [708](/filings/0001534254-26-000010.md) | [660](/filings/0001534254-26-000010.md) | [668](/filings/0001534254-26-000010.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.9)](/filings/0001534254-24-000020.md) | [(54.6) d](/filings/0001534254-26-000003.md) | [96.4](/filings/0001534254-25-000009.md) | [(16.7)](/filings/0001534254-25-000012.md) | [52.0](/filings/0001534254-25-000015.md) | [(43.4) d](/filings/0001534254-26-000003.md) | [6.1](/filings/0001534254-26-000006.md) | [43.5](/filings/0001534254-26-000010.md) | [44.4](/filings/0001534254-25-000015.md) | [(17.1) d](/filings/0001534254-26-000010.md) | [(4.6)](/filings/0001534254-26-000006.md) | [21.6](/filings/0001534254-26-000010.md) |
| Dividends paid | $m | [18.6](/filings/0001534254-24-000020.md) | [21.2 d](/filings/0001534254-26-000003.md) | [29.1](/filings/0001534254-25-000009.md) | [19.3](/filings/0001534254-25-000012.md) | [21.9](/filings/0001534254-25-000015.md) | [19.2 d](/filings/0001534254-26-000003.md) | [2.7](/filings/0001534254-26-000006.md) | [38.1](/filings/0001534254-26-000010.md) | [18.7](/filings/0001534254-25-000015.md) | [18.6 d](/filings/0001534254-26-000010.md) | [15.2](/filings/0001534254-26-000006.md) | [14.8](/filings/0001534254-26-000010.md) |
| Share repurchases | $m | [1.8](/filings/0001534254-24-000020.md) | [2.9 d](/filings/0001534254-26-000003.md) | [4.7](/filings/0001534254-25-000009.md) | [2.7](/filings/0001534254-25-000012.md) | [2.0](/filings/0001534254-25-000015.md) | [2.0 d](/filings/0001534254-26-000003.md) | [2.2](/filings/0001534254-26-000006.md) | [6.6](/filings/0001534254-26-000010.md) | [3.3](/filings/0001534254-25-000015.md) | [5.2 d](/filings/0001534254-26-000010.md) | [9.7](/filings/0001534254-26-000006.md) | [8.0](/filings/0001534254-26-000010.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [54.6](/filings/0001534254-25-000004.md) | [54.3](/filings/0001534254-25-000004.md) | [54.0](/filings/0001534254-26-000003.md) | [53.6](/filings/0001534254-26-000003.md) | [53.4](/filings/0001534254-26-000003.md) | [53.3](/filings/0001534254-26-000003.md) | [53.1](/filings/0001534254-26-000006.md) | [52.6](/filings/0001534254-26-000010.md) | [52.1](/filings/0001534254-26-000003.md) | [51.6](/filings/0001534254-26-000003.md) | [50.8](/filings/0001534254-26-000006.md) | [49.7](/filings/0001534254-26-000010.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 49,202,704 at 2026-07-29, from the cover of the [10-Q filed 2026-08-06](/filings/0001534254-26-000010.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.